Search Results for "Biochemistry Leukemia"

02:48 EDT 7th July 2015 | BioPortfolio

Matching Channels

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Chronic Myelocytic Leukemia CML

Chronic myelocytic leukemia is the resulting disease when neutrophil, basophil, eosinophil, and monocyte progenitors become cancerous. It is usually caused by the presence of the Philadelphia chromo...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Matching News

Paucity of Somatic Mutations in Aggressive Childhood Leukemia

In-depth DNA sequencing and RNA expression analysis shows that a particularly aggressive form of infant and childhood leukemia--mixed-lineage leukemia-rearranged gene (MLL-R) acute lymphoblastic leuke...

Researchers effectively, safely overcome radiation resistance in leukemia with an engineered precision medicine

Improved survival rates have been demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients, according to a new study.

Promising drug a 'new paradigm' for treating leukemia

Researchers at the University of Virginia School of Medicine have developed a compound that delays leukemia in mice and effectively kills leukemia cells in human tissue samples, raising hopes that the...

Leukemia like Achilles, has its own weakness

Leukemia cells from patients suffering from chronic myeloid leukemia, especially in the advanced stage, lack one of the proteins: the famous BRCA1. Importantly, the protein is not present even if the ...

Leukemia-associated mutations almost inevitable as we age

(Wellcome Trust Sanger Institute) It's almost inevitable that we'll develop mutations associated with leukemia as we age, according to research today in Cell Reports. These mutations are more common t...

Minimal residual disease alone not predictive in T-cell leukemia

Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. This disease includes two subtypes, B-cell and T-cell leukemia, depending upon the type of white blood cell where the leukemia o...

Noncoding RNA CCDC26 regulates KIT expression

A long, noncoding RNA (lncRNA), which might have impact on tyrosine kinase-targeted leukemia therapy, was found to be expressed in a leukemia cell line. The function of the lncRNA CCDC26 is not fully ...

Management of Myelofibrosis that Progresses to Acute Myeloid Leukemia

In some patients with myelofibrosis, the condition progresses to a type of leukemia known as acute myeloid leukemia (AML). Information about the management of AML is available here. http://news.cancer...

Matching PubMed Articles

Faggot-like cells observed in acute myeloid leukemia with myelodysplasia-related changes mimicking acute promyelocytic leukemia.

Curcumin Potentiates the Anti-leukemia Effects of Imatinib by Downregulation of the AKT/mTOR Pathway and BCR/ABL Gene Expression in Ph+ Acute Lymphoblastic Leukemia.

Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is triggered by BCR/ABL and SRC family tyrosine kinases. They interact with each other and subsequently activate downstream grow...

Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.

B-lymphoblastic leukemia (B-ALL) with intrachromosomal amplification of chromosome 21 (iAMP21) is a relatively uncommon manifestation of acute leukemia and limited predominantly to the pediatric popul...

The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Usually, an effective anti-leukemia immune response cannot be initiated effectively in patients with leukemia. This is probably related to immunosuppression due to chemotherapy, down-regulation of maj...

Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia.

Abstract Objective: Azacitidine (Vidaza ) is approved in Europe for treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) with 20-30% bone marrow (BM) blasts, and chronic myelomon...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement